The original shielding letters and advice that have been sent out to people who are highly vulnerable to COVID-19 (coronavirus) infection stated that all recipients of the letter should completely isolate themselves from physical contact, not go outside of their homes for 12 weeks.
This advice was sent to all patients of the National Aspergillosis Centre (NAC) who have chronic pulmonary aspergillosis (CPA).
Patients who have allergic bronchopulmonary aspergillosis (ABPA), severe asthma and forms of aspergillosis other than CPA were informed of their vulnerability status by their local respiratory clinic or GP. Some will have been told to shield, others not but all shielding advice was to remain in place for 12 weeks from the day of receipt of the letter.
That advice for people shielding has now been amended to say that all shielding people should continue shielding until the end of June 2020.
Latest advice from Welsh government
Share this post
Latest News posts
Patients & Carers meeting January 2017
January 11, 2019
Patients & Carers meeting December 2016
January 11, 2019
Patients & Carers meeting November 2016
January 11, 2019
Patients & Carers meeting October 2016
January 11, 2019
Patients & Carers meeting September 2016
January 11, 2019
Patients & Carers meeting August 2016
January 11, 2019
Patients & Carers meeting July 2016
January 11, 2019
Patients & Carers meeting June 2016
January 11, 2019
Patients & Carers meeting May 2016
January 11, 2019
Patients & Carers meeting April 2016
January 11, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video